NEU 3.50% $14.05 neuren pharmaceuticals limited

Updated MST report - target of $3.68 a share, page-139

  1. 1,821 Posts.
    lightbulb Created with Sketch. 131
    The analytics behind this whole thread are bogus!
    The people who peddle risk weighted DCF are charlatans!
    The people who use risk weighted DCF are fools!
    Probabilities must be based on quantatitave analysis!
    The value of a 20% probability of a $10 outcome is NOT $2!
    A 20% probability of a $10 outcome means that 80% of the possible outcomes are NOT $2 and are likely to be $0!!!!

    Having said all that NEU, though risky, has IP that testing could be valuable.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.